Success Metrics

Clinical Success Rate
66.7%

Based on 4 completed trials

Completion Rate
67%(4/6)
Active Trials
1(9%)
Results Posted
0%(0 trials)
Terminated
2(18%)

Phase Distribution

Ph phase_3
1
9%
Ph not_applicable
5
45%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 3Large-scale testing
1(16.7%)
N/ANon-phased studies
5(83.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(4)
Terminated(2)
Other(4)

Detailed Status

Completed4
unknown4
Terminated2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
66.7%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (16.7%)
N/A5 (83.3%)

Trials by Status

terminated218%
completed436%
unknown436%
recruiting19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
OTHER
Total Trials
11